Theranostics could pave way for cancer cures, Madison researchers say
Wisconsin has become an emerging hub for studying and developing theranostics, an approach to treating cancer, according to local researchers....
19 September, 2024
Clinical Trials
Considering the Benefits of Music: Not All Alzheimer’s Treatments are Pills or Shots
In recognition of September being World Alzheimer’s Month, ACRP sought out commentary on a type of therapy for the disease that’s not as well known to the public as the recently approved pharmaceuticals....
19 September, 2024
Care Everywhere and Research
Several questions have recently arisen regarding the use of the Care Everywhere platform for research purposes at UW–Madison and UW Health....
18 September, 2024
Building trust with a Native community
Tribal council’s historic visit strengthens relationship with UW’s health researchers...
17 September, 2024
The burden of a gene
A gene variant called APOE4 is notorious for its link to Alzheimer’s. Can new insights into its function help stave off disease?...
12 September, 2024
Dedicated Trialist, Nurse Navigators Help Advance Cancer Therapy Into Accelerated Approval
A conversation with Sally Lau, MD, thoracic medical oncologist, Perlmutter Cancer Center, NYU Langone Health...
11 September, 2024
Team Spotlight: Meg Marie Hackbarth
Meg Marie Hackbarth discusses her career path and current role as Clinical Research Coordinator II within the UW Clinical Trials Institute....
11 September, 2024
Diversity Action Plans for Clinical Trials: Evaluating FDA’s Draft Guidance
The FDA is intent on improving the enrollment of participants -- also known as "subjects" -- from underrepresented populations in clinical studies for drugs and devices....
06 September, 2024
Grants power two decades of statewide impact
Wisconsin Partnership Program advances health and shapes the School of Medicine and Public Health...
05 September, 2024
A Perspective on Possible Applications of Artificial Intelligence to the Clinical Trial Workforce
The pharmaceutical industry has begun leveraging artificial intelligence (AI) to streamline numerous aspects of drug development from identification of novel drug targets to clinical trial design....
04 September, 2024